Skip to main content
. 2018 Aug 31;103(11):1772–1784. doi: 10.3324/haematol.2018.189159

Table 5.

Recent studies on minimal residual disease and the implications for progression-free and overall survival of patients with multiple myeloma.

graphic file with name 1031772.tab5.jpg